{"schema_version":"1","generated_at":"2026-11-21T15:56:37.885Z","data_as_of":null,"url":"https://www.findmykol.com/kol/antonio-guasch","json_url":"https://www.findmykol.com/kol/antonio-guasch/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"antonio-guasch","name":"Antonio Guasch","credential":"MD","specialty":"Nephrology","specialty_raw":"Nephrology","therapeutic_area":"Nephrology","therapeutic_areas":["Nephrology"],"institution":"Emory University","institution_url":"https://www.findmykol.com/institution/emory-university","city":"Atlanta","state":"GA","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"on_file":["npi","openalex"],"values":"Shown on the profile page to a signed-in account."},"summary":"Antonio Guasch is a Nephrology physician affiliated with Emory University. OpenAlex indexes 49 publications with 4,048 citations (h-index 27); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Nephrology"]},"scholarship":{"works_count":49,"cited_by_count":4048,"h_index":27,"latest_activity_year":2026,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT00565773","title":"Belatacept Post Depletional Repopulation to Facilitate Tolerance","phase":"PHASE2","status":"COMPLETED","role":"Overall official","sponsor":"Allan D Kirk, MD, PhD","source_url":"https://clinicaltrials.gov/study/NCT00565773","trial_url":"https://www.findmykol.com/trial/NCT00565773"}],"source":"trials"},"payments":{"company_count":2,"program_years":{"first":2021,"last":null},"rows_total":3,"shown":3,"withheld":0,"rows":[{"payer":"Apellis Pharmaceuticals, Inc.","program_year":2025,"amount_usd":120.19,"payment_count":1},{"payer":"Aurinia Pharma U.S., Inc.","program_year":2022,"amount_usd":19.69,"payment_count":1},{"payer":"Travere","program_year":2021,"amount_usd":1661.8,"payment_count":1}],"source":"payments"},"prescribing":{"data_year":2023,"areas_total":8,"areas_shown":3,"areas":[{"area":"Cardiovascular","share_pct":52.1,"classes_total":8,"classes":[{"class":"Statin","setting":"prescribed","share_pct":13.9,"drugs":[{"name":"Atorvastatin Calcium","share_pct":69.6},{"name":"Rosuvastatin Calcium","share_pct":16.6},{"name":"Pravastatin Sodium","share_pct":9.1},{"name":"Simvastatin","share_pct":4.7}],"max_beneficiaries":null},{"class":"Beta blocker","setting":"prescribed","share_pct":13.7,"drugs":[{"name":"Carvedilol","share_pct":35.5},{"name":"Metoprolol Tartrate","share_pct":33.5},{"name":"Metoprolol Succinate","share_pct":25.8},{"name":"Labetalol Hcl","share_pct":5.2}],"max_beneficiaries":null}]},{"area":"Metabolism & gastrointestinal","share_pct":27.8,"classes_total":6,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":15.2,"drugs":[{"name":"Prednisone","share_pct":100}],"max_beneficiaries":67},{"class":"Proton pump inhibitor","setting":"prescribed","share_pct":6,"drugs":[{"name":"Pantoprazole Sodium","share_pct":63.9},{"name":"Omeprazole","share_pct":24.1},{"name":"Esomeprazole Magnesium","share_pct":12}],"max_beneficiaries":null}]},{"area":"Hormonal (systemic)","share_pct":6.9,"classes_total":3,"classes":[{"class":"Calcium-sensing Receptor Agonist","setting":"prescribed","share_pct":5.5,"drugs":[{"name":"Cinacalcet Hcl","share_pct":100}],"max_beneficiaries":17},{"class":"Mineralocorticoids","setting":"prescribed","share_pct":0.8,"drugs":[{"name":"Fludrocortisone Acetate","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2023,"office_pct":7.8,"facility_pct":92.2},"source":"medicare"},"funding":{"award_count":4,"fiscal_years":{"first":1997,"last":2010},"rows_total":24,"shown":3,"withheld":21,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"R01DK081699","title":"The Pathogenesis of Sickle Cell Nephropathy","fiscal_year":2010,"amount_usd":"350001","organization":"EMORY UNIVERSITY","source_url":"https://reporter.nih.gov/quickSearch/R01DK081699"},{"project":"R01DK081699","title":"The Pathogenesis of Sickle Cell Nephropathy","fiscal_year":2010,"amount_usd":"77500","organization":"EMORY UNIVERSITY","source_url":"https://reporter.nih.gov/quickSearch/R01DK081699"},{"project":"R01DK081699","title":"The Pathogenesis of Sickle Cell Nephropathy","fiscal_year":2009,"amount_usd":"350001","organization":"EMORY UNIVERSITY","source_url":"https://reporter.nih.gov/quickSearch/R01DK081699"}],"source":"grants"},"publications":{"total":49,"shown":5,"withheld":44,"matched_by":"OpenAlex author record","recent":[{"title":"Decoding CD8 Alloimmunity in the Rejecting Kidney Microenvironment","year":2026,"journal":"American Journal of Transplantation","source_url":"https://doi.org/10.1016/j.ajt.2026.05.365","status":"verified"},{"title":"Belatacept in Kidney Transplant Recipients With Failed Allografts for the Prevention of Humoral Sensitization: A Pilot Randomized Controlled Trial","year":2021,"journal":"Transplantation","source_url":"https://doi.org/10.1097/tp.0000000000003852","status":"verified"},{"title":"Kidney transplantation using alemtuzumab, belatacept, and sirolimus: Five-year follow-up","year":2020,"journal":"American Journal of Transplantation","source_url":"https://doi.org/10.1111/ajt.16121","status":"verified"},{"title":"Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial","year":2019,"journal":"The Lancet","source_url":"https://doi.org/10.1016/s0140-6736(19)30772-x","status":"verified"},{"title":"B cell reconstitution following alemtuzumab induction under a belatacept-based maintenance regimen","year":2019,"journal":"American Journal of Transplantation","source_url":"https://doi.org/10.1111/ajt.15639","status":"verified"}],"source":"works"},"similar":[{"name":"Allan Levey","slug":"allan-levey","institution":"Emory University","specialty":"Neurology","url":"https://www.findmykol.com/kol/allan-levey","json_url":"https://www.findmykol.com/kol/allan-levey/profile.json"},{"name":"Craig Coopersmith","slug":"craig-coopersmith","institution":"Emory University","specialty":"Critical Care Medicine","url":"https://www.findmykol.com/kol/craig-coopersmith","json_url":"https://www.findmykol.com/kol/craig-coopersmith/profile.json"},{"name":"James Lah","slug":"james-lah","institution":"Emory University","specialty":"Neurology","url":"https://www.findmykol.com/kol/james-lah","json_url":"https://www.findmykol.com/kol/james-lah/profile.json"},{"name":"Vasilis Babaliaros","slug":"vasilis-babaliaros","institution":"Emory University","specialty":"Interventional Cardiology","url":"https://www.findmykol.com/kol/vasilis-babaliaros","json_url":"https://www.findmykol.com/kol/vasilis-babaliaros/profile.json"},{"name":"Laura Svetkey","slug":"laura-svetkey","institution":"Duke University","specialty":"Nephrology","url":"https://www.findmykol.com/kol/laura-svetkey","json_url":"https://www.findmykol.com/kol/laura-svetkey/profile.json"},{"name":"Prasad Devarajan","slug":"prasad-devarajan","institution":"Cincinnati Children's Hospital Medical Center","specialty":"Pediatric Nephrology","url":"https://www.findmykol.com/kol/prasad-devarajan","json_url":"https://www.findmykol.com/kol/prasad-devarajan/profile.json"},{"name":"Rajesh V. Thakker","slug":"rajesh-thakker","institution":"Queen Mary University of London","url":"https://www.findmykol.com/kol/rajesh-thakker","json_url":"https://www.findmykol.com/kol/rajesh-thakker/profile.json"},{"name":"Paul Kimmel","slug":"paul-kimmel","specialty":"Nephrology","url":"https://www.findmykol.com/kol/paul-kimmel","json_url":"https://www.findmykol.com/kol/paul-kimmel/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"funding":21,"publications":44}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}